News|Articles|November 6, 2026
Next-Generation Breast Imaging Platform to be Unveiled at RSNA
Author(s)Jeff Hall
Report One, reportedly the first agentic reporting tool specifically geared to breast imaging, is one of three new products that will be showcased by MagView at the upcoming RSNA conference.
Advertisement
Emphasizing enhanced capabilities and efficiencies for breast imaging workflows, MagView will be featuring an array of new products at the
For breast radiologists looking for an alternative approach for structured reporting, MagView will be debuting Report One,
The next-generation MagView One combines advanced patient tracking and risk assessment and management with patient education and communication in one online platform, according to MagView.
Employing the technology behind Therapixel’s MammoScreen QC software, MagView said Quality One provides mammography technologists with AI quality analytics on patient positioning and compression to help ensure high-quality images.
“MagView One, Report One, and Quality One represent the next generation of breast imaging technology. Each was shaped by the insight of our customers, and we look forward to showcasing what we’ve built together,” noted Mark Schmidt, the vice president of sales and marketing at MagView.
(Editor’s note: The Radiological Society of North America (RSNA) conference takes place November 29 to December 3, 2026 in Chicago. For more info, visit
Advertisement
Related to this article
While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.
Use of the AI-enabled slab technology from reconstructed DBT imaging led to a 7.4-second mean reduction in reading time in a new study involving 391 cases and 15 reviewing radiologists.
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
Artificial intelligence plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume, according to a new study to be presented at the American Heart Association Scientific Sessions 2026 this week.
New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.
Catch up on the top radiology content of the past week.
In a recent interview with Diagnostic Imaging, Eliad Josephson discussed key attributes of the HLTH USA conference, AI trends and an ongoing shift of emphasis on the development of predictive technologies with diagnostics at center stage.
In a recent interview, Phillip Koo, MD, discussed emerging trends with AI, theranostics and empowered patients, and how these developments may lead to challenges and potential opportunities for radiologists and nuclear medicine physicians.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
CCTA Study: AI-Powered Plaque Analysis Reveals Coronary Plaque in 87 Percent of Retired NFL Players
2
FDA Clears Emerging AI-Enabled Platform for Intravascular Ultrasound
3
A Closer Look at the P4 Trial and CCTA-Guided PCI
4
Addressing Radiology’s Workforce Crisis: Can a Shift from Being Passive AI Users to Active AI Creators Have an Impact?
5